Power3 Medical Announces Filing of Two Provisional Patent Applications with the USPTO
Power3 Medical Announces Filing of Two Provisional Patent Applications with the USPTO
HOUSTON—-Power3 Medical Products, Inc. announced today that it has filed two provisional patent applications with the United States Patent and Trademark Office – one on Alzheimer’s disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer’s disease patients.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Treatment Options Tags: Announces, Applications, Filing, Medical, Patent, Power3, Provisional, USPTO
Medical calendar for May 19
Medical calendar for May 19
Blood drives BLOOD DRIVE: noon-6 p.m. May 28 at Truesdale Knights of Columbus Hall, 700 South St. Sponsored by the Warren County Ambulance District and American Red Cross. To make an appointment, visit www.redcrossblood.org and enter sponsor code WarrenCoAmDist. Donors will receive a T-shirt and should bring photo ID.
Read more on Suburban Journals
Categories: Breast Cancer Treatment Options Tags: calendar, Medical
Simple, cheap drug holds cancer treatment promise
Simple, cheap drug holds cancer treatment promise
An inexpensive drug already in use for other diseases might hold the key to a completely new way of treating cancers — not by killing off cancer cells, but by simply reprogramming them.
Read more on CTV.ca
Categories: Breast Cancer Treatment Options Tags: cancer, cheap, drug, Holds, Promise, SIMPLE, Treatment
Medical calendar for May 12
Medical calendar for May 12
Classes AUTISM: Autism Education and Support Services hosts Strategies for Challenging Behaviors from 6-8 p.m. the fourth Tuesday of each month at The Center for Autism Education, 105 Sheriff Dierker Court in O’Fallon. Classes are designed for parents, grandparents, baby sitters, friends or other family members who want to learn more about autism. Cost is $30. To register, call 636-978-4951.
Read more on Suburban Journals
Categories: Breast Cancer Treatment Options Tags: calendar, Medical
Hormone hope in new study
Hormone hope in new study
A form of oestrogen that directly targets the brain is effective in reducing the symptoms of schizophrenia, Melbourne researchers have found.
Read more on The Age
Categories: Breast Cancer Treatment Options Tags: hope, Hormone, Study
Strength in support
Strength in support
Deb Mumma, a local nurse fighting metastatic breast cancer — Stage 4 cancer — is starting a support group for others facing the life challenges she now faces.
Read more on Chambersburg Public Opinion
Categories: Breast Cancer Treatment Options Tags: strength, Support
New technology aids in prostate cancer treatment
New technology aids in prostate cancer treatment
Researchers at Queen’s University have developed a new way of performing lab tests that could improve the way doctors manage prostate cancer treatment. It will allow them to identify with unprecedented accuracy losses of a gene called PTEN that is associated with an aggressive group of prostate cancers.
Read more on PhysOrg
Categories: Breast Cancer Treatment Options Tags: Aids, cancer, prostate, technology, Treatment
Health happenings
Health happenings
Looking for a certain support group or workshop? Check out our local roundup of everything from health screenings to child car seats.
Read more on Fort Worth Star-Telegram
Categories: Breast Cancer Treatment Options Tags: happenings, health
IBM to analyze best way to cut childhood obesity
IBM to analyze best way to cut childhood obesity
IBM “will put computer models to work analyzing the reams of available data on the different factors that might affect obesity – things such as consumer behavior, the location of grocery stores, the availability of physical activity facilities and even community transportation options – and see how those factors interact.
Read more on News-Medical-Net
Categories: Breast Cancer Treatment Options Tags: Analyze, best, childhood, Obesity
Incyte Reports First Quarter 2010 Financial Results
Incyte Reports First Quarter 2010 Financial Results
WILMINGTON, Del.—-Incyte Corporation today reported first quarter 2010 financial results and provided an update on recent clinical accomplishments, including positive top-line results from an ongoing six-month, dose-ranging Phase II trial to evaluate INCB28050 in rheumatoid arthritis patients.
Read more on Business Wire via Yahoo! Finance
